Evidence map›Paper›PMID 29967349›Full record

ArticleNature medicine2018

DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia.

Darren C Johnson, Cornelius Y Taabazuing, Marian C Okondo, Ashley J Chui, Sahana D Rao, Fiona C Brown, Casie Reed, Elizabeth Peguero, Elisa de Stanchina, Alex Kentsis and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 230 papers.

0numbers the graph read from it
0cells of the map it votes in
230citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

230 citing papers in PubMed, 352 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. An overview of human inflammasomes: Activation and regulation.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  13. Pyroptosis: Turning Up the Heat on Cancer.Annual review of immunology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

170 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Darren C JohnsonTri-institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cornelius Y TaabazuingChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marian C OkondoChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ashley J ChuiTri-institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sahana D RaoTri-institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Fiona C BrownMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Casie ReedMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elizabeth PegueroAntitumor Assessment Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elisa de StanchinaAntitumor Assessment Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alex KentsisTri-institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-8063-9191
Daniel A BachovchinTri-institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bachovcd@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
MSKCC Pilot Center for Precision Disease ModelingU54OD020355 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI LOWE, SCOTT W., SOLIT, DAVID B. · 2015 to 2019
$9.9M
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIAR01CA204396 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI KENTSIS, ALEX · 2016 to 2025
$5.2M
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced PyroptosisR01AI137168 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Daniel Bachovchin · 2018 to 2026
$4.3M
Tri-Institutional PhD Program in Chemical BiologyT32GM115327 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TAN, DEREK S · 2015 to 2019
$741k
Phosphoproteomic signatures for early detection and stratification of AMLR21CA188881 · NCI · DANA-FARBER CANCER INST · PI KENTSIS, ALEX, MARTO, JARROD A. · 2015 to 2016
$420k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA204396NCI NIH HHS R21 CA188881NIAID NIH HHS R01 AI137168NIGMS NIH HHS T32 GM115327NIH HHS U54 OD020355Wellcome Trust
6 · The paper itself

Abstract

Small-molecule inhibitors of the serine dipeptidases DPP8 and DPP9 (DPP8/9) induce a lytic form of cell death called pyroptosis in mouse and human monocytes and macrophages

Indexed as

CARD Signaling Adaptor ProteinsCaspase 1Cell Line, TumorDipeptidyl-Peptidases and Tripeptidyl-PeptidasesDisease ProgressionHEK293 CellsHumansLeukemia, Myeloid, AcuteProtease InhibitorsPyroptosisCARD Signaling Adaptor ProteinsCaspase 1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesProtease Inhibitors

Identifiers

PMID29967349
PMCPMC6082709
OpenAlexW2810326672

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.